Citibank: Initiates coverage of Eastroc Beverage (09980) with a "Buy" rating and a target price of 408.8 Hong Kong dollars.
According to the forecast, Dongpeng Beverage's net profit in the next two years is expected to increase by 27% and 22% respectively, making it one of the fastest-growing companies among the Chinese consumer goods companies covered by the bank.
Citigroup released a research report stating that due to the limited number of high-quality beverage companies available for global institutional investors to choose from in the Hong Kong market, the bank has initiated coverage on Eastroc Beverage (09980) for the first time, giving it a "buy" rating with a target price of 408.8 Hong Kong dollars.
The bank predicts that Eastroc Beverage's net profit will increase by 27% and 22% in the next two years, making it one of the fastest-growing companies among the Chinese consumer goods companies covered by the bank. The bank is optimistic about Eastroc Beverage's continued strong growth in new product categories (including sports drinks and other beverages) in the next two years, as well as its expansion in non-Guangdong markets. Eastroc Beverage remains one of the bank's top picks in the Chinese consumer sector for 2026.
Citigroup's relative ranking of companies in the Chinese beverage industry is Eastroc Beverage, Nongfu Spring (09633), and U-PRESID China (00220), all of which have a "buy" rating. On the other hand, Master Kong (00322) has a "sell" rating.
Related Articles

HK Stock Market Move | Biocytogen Pharmaceuticals-B(02315) rises by more than 5%, main business prosperity drives high income growth, institutions are optimistic about the company's long-term growth potential.

HK Stock Market Move | Some coal stocks have further expanded their gains, Indonesian mineral traders have temporarily suspended the export of spot coal, institutions are optimistic about overseas layout coal companies.

A-share market closing review | The market rebounded in the last two days of trading, with the Shanghai Composite Index closing up by 0.85% to surpass the 4100 points mark. The photovoltaic sector experienced an overall surge.
HK Stock Market Move | Biocytogen Pharmaceuticals-B(02315) rises by more than 5%, main business prosperity drives high income growth, institutions are optimistic about the company's long-term growth potential.

HK Stock Market Move | Some coal stocks have further expanded their gains, Indonesian mineral traders have temporarily suspended the export of spot coal, institutions are optimistic about overseas layout coal companies.

A-share market closing review | The market rebounded in the last two days of trading, with the Shanghai Composite Index closing up by 0.85% to surpass the 4100 points mark. The photovoltaic sector experienced an overall surge.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


